Evidence-based medicine
Researchers at the Oklahoma State University Center for Health Sciences conducted a systematic review of 169 migraine headache (MH) randomized controlled trials (RCTs) to identify common shortcomings in design and reporting, highlight trial features that enhance value to practicing clinicians, and offer recommendations that improve the alignment between MH research
Medical research
Researchers at the University of Valencia, Spain, have published a systematic review and meta-analysis of the relationship between migraine and periodontitis. According to the study, published in the European Journal of Neurology, individuals with periodontitis are 1.8 times more likely to experience migraine, with a significant association found between
Migraine
Research conducted at Beni-Suef University in Egypt has uncovered a link between altered eating behaviors and the onset of migraine in adults. The study found that individuals with migraine exhibited different eating behaviors compared to healthy controls, indicating a potential association between the two. The findings suggest that health professionals
Evidence-based medicine
Researchers at the Oklahoma State University Center for Health Sciences conducted a systematic review of 169 migraine headache (MH) randomized controlled trials (RCTs) to identify common shortcomings in design and reporting, highlight trial features that enhance value to practicing clinicians, and offer recommendations that improve the alignment between MH research
Evidence-based medicine
Researchers at the Oklahoma State University Center for Health Sciences conducted a systematic review of 169 migraine headache (MH) randomized controlled trials (RCTs) to identify common shortcomings in design and reporting, highlight trial features that enhance value to practicing clinicians, and offer recommendations that improve the alignment between MH research
Migraine
Research conducted at Beni-Suef University in Egypt has uncovered a link between altered eating behaviors and the onset of migraine in adults. The study found that individuals with migraine exhibited different eating behaviors compared to healthy controls, indicating a potential association between the two. The findings suggest that health professionals
Medical research
Researchers at the University of Valencia, Spain, have published a systematic review and meta-analysis of the relationship between migraine and periodontitis. According to the study, published in the European Journal of Neurology, individuals with periodontitis are 1.8 times more likely to experience migraine, with a significant association found between
Evidence-based medicine
Researchers at the Oklahoma State University Center for Health Sciences conducted a systematic review of 169 migraine headache (MH) randomized controlled trials (RCTs) to identify common shortcomings in design and reporting, highlight trial features that enhance value to practicing clinicians, and offer recommendations that improve the alignment between MH research
Evidence-based medicine
Researchers at the Oklahoma State University Center for Health Sciences conducted a systematic review of 169 migraine headache (MH) randomized controlled trials (RCTs) to identify common shortcomings in design and reporting, highlight trial features that enhance value to practicing clinicians, and offer recommendations that improve the alignment between MH research
Child health
A new population pharmacokinetic model for oral rimegepant has been developed and used to predict exposure in a virtual pediatric population generated using United States national growth charts. The study's results suggest that exposure with rimegepant 75 mg orally disintegrating tablet was evaluated in simulated participants aged 6
Migraine
A phase 3 trial, PRECLUDE, investigated the efficacy of onabotulinumtoxinA (onabotA) for preventing episodic migraine, a complex neurological disease characterized by recurring headache attacks. The study involved 775 patients aged 18-65 years, who were randomized to receive placebo, onabotA 155 U, or onabotA 195 U. The trial protocol included a
Migraine
A phase 3 trial, PRECLUDE, investigated the efficacy of onabotulinumtoxinA (onabotA) for preventing episodic migraine, a complex neurological disease characterized by recurring headache attacks. The study involved 775 patients aged 18-65 years, who were randomized to receive placebo, onabotA 155 U, or onabotA 195 U. The trial protocol included a
